Cheong Kwang Soo 4
4 · REXAHN PHARMACEUTICALS, INC. · Filed Oct 25, 2010
Insider Transaction Report
Form 4
Cheong Kwang Soo
Director
Transactions
- Award
Stock Options (right-to-buy)
2010-06-14+20,000→ 20,000 totalExercise: $1.17Exp: 2020-06-14→ Common Stock (20,000 underlying)
Holdings
- 3,000
Common Stock
- 20,000
Stock Options (right-to-buy)
Exercise: $1.28From: 2010-06-01Exp: 2019-06-01→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.40From: 2008-06-11Exp: 2017-06-11→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $3.24From: 2009-06-30Exp: 2018-06-30→ Common Stock (20,000 underlying) - 20,000
Stock Options (right-to-buy)
Exercise: $1.20From: 2007-05-01Exp: 2016-05-01→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]These options vest and become exercisable in full on June 14, 2011.